News from the healthcare data industry
June 17, 2022 – As efforts to reduce and eventually eliminate cancer, such as President Biden’s Cancer Moonshot, gain traction, providers are tasked with finding ways to improve cancer care delivery and research. As a result, the healthcare industry has seen significant progress in the areas of precision medicine and personalized cancer care….
Lynx and Clalit will work together to facilitate medical research, development, and new opportunities for healthcare data innovation PALO ALTO, Calif., June 16, 2022 /PRNewswire/ — Lynx MD and Clalit Health Services, the largest provider of public and semi-private health services in Israel, today announced a partnership to provide access to Clalit’s extensive medical database via…
In a retrospective cohort study reported in JAMA Network Open, Sanjay Popat, FRCP, PhD, and colleagues found that among patients initiating first-line pembrolizumab for EGFR and ALK wild-type advanced non–small cell lung cancer (NSCLC), ever-smokers had significantly better overall survival vs never-smokers. Study Details The study involved data from the Flatiron Health database, a nationwide longitudinal…
Tempus, a leader in artificial intelligence and precision medicine, today announced a collaboration with Intermountain Healthcare, a Utah-based, nonprofit healthcare system, which leverages genomic testing and data analytics to advance research intended to improve outcomes for cancer patients. Intermountain Healthcare is leveraging Tempus’ solid tumor/normal genomic test, xT, to generate…
By Jim Robbins In December 2021, the FDA issued draft guidance to lifescience researchers on evaluating EHR and claims data in studies to support regulatory decisions. This new draft guidance covers using real-world data (RWD) from these sources to support regulatory decisions on both safety and effectiveness. Overall, the FDA guidance…
BD is among the first companies to enter innovative partnership with Mayo Clinic Platform for access to world’s largest collection of clinical data FRANKLIN LAKES, N.J., June 13, 2022 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a collaboration with Mayo Clinic Platform to…
The bipartisan bill would reform the FDA pathway that provides early access to treatments for patients with serious and life-threatening conditions Washington, D.C.—U.S. Senators Susan Collins (R-ME) and Tim Kaine (D-VA), members of the Senate Health, Education, Labor, and Pensions (HELP) Committee, announced that the Modernizing Accelerated Approval Act they co-authored advanced…
June 15, 2022 09:15 AM Eastern Daylight Time ST. LOUIS–(BUSINESS WIRE)–Pierian®, a global leader in advanced clinical genomics technology and services, announced with Syapse®, a leading real-world evidence company, a new joint collaboration that will benefit patients of the AdventHealth Cancer Institute in Central Florida. The collaboration combines Pierian’s leading-edge clinical genomics…
Boston, MA, June 15, 2022 –(PR.com)– PharmStars, the pharma-focused accelerator for digital health startups, is pleased to announce that it is now accepting applications for its Fall 2022 cohort with the theme, “Innovations in Real-World Evidence.” Data gathered from wearables, mobile devices, and other digital tools can yield reliable, usable clinical…
Relative to white patients, racial and ethnic groups saw a sharper decline in access to medicines to treat opioid use disorder during the early stages of the COVID-19 pandemic—intensifying pre-pandemic disparities, says a University of Michigan researcher. “We found that COVID-19 was associated with widened racial and ethnic disparities in …